Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.62M Sell
11,587
-4
-0% -$3.38K 0.19% 102
2026
Q1
$8.56M Sell
11,591
-1,067
-8% -$777K 0.19% 104
2025
Q4
$7.74M Sell
12,658
-270
-2% -$175K 0.17% 117
2025
Q3
$8.4M Sell
12,928
-1,288
-9% -$781K 0.27% 76
2025
Q2
$7.6M Buy
14,216
+12,903
+983% +$5.69M 0.24% 91
2025
Q1
$485K Sell
1,313
-2,066
-61% -$894K 0.04% 328
2024
Q4
$1.53M Buy
3,379
+2,113
+167% +$1,000K 0.1% 180
2024
Q3
$545K Buy
1,266
+184
+17% +$69.4K 0.09% 100
2024
Q2
$395K Buy
+1,082
New +$399K 0.08% 105

Other funds holding EME

Callan Family Office's EME Position: Q2 2026 in Review

Callan Family Office reduced its Emcor (EME) stake by 0.03% in Q2 2026, selling an estimated $3.38K and leaving 11,587 shares worth $9.62M. The position accounts for 0.19% of the portfolio, ranked #102.

Callan Family Office first reported a position in EME in Q2 2024 and has held it in 9 quarters since. 1,251 funds tracked by Wall St. Rank hold EME as of Q2 2026.

  • Callan Family Office held 11,587 shares of Emcor worth $9.62M as of Q2 2026.
  • Callan Family Office sold 4 Emcor shares in Q2 2026, an estimated $3.38K.
  • Emcor made up 0.19% of Callan Family Office's portfolio in Q2 2026, its #102 holding.
  • Callan Family Office first reported a position in Emcor in Q2 2024 and has held it in 9 quarters since.
  • 1,251 funds tracked by Wall St. Rank held Emcor as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.